BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38229155)

  • 1. Construction of an ER stress-related prognostic signature for predicting prognosis and screening the effective anti-tumor drug in osteosarcoma.
    Chen W; Liao Y; Sun P; Tu J; Zou Y; Fang J; Chen Z; Li H; Chen J; Peng Y; Wen L; Xie X
    J Transl Med; 2024 Jan; 22(1):66. PubMed ID: 38229155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma.
    Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L
    Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an EMT-related gene-based prognostic signature in osteosarcoma.
    Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; Zeng M; Liu Y; Chen Y
    Cancer Med; 2023 Jun; 12(11):12912-12928. PubMed ID: 37102261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma.
    He L; Yang H; Huang J
    BMC Cancer; 2021 May; 21(1):581. PubMed ID: 34016089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis.
    Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H
    Front Immunol; 2022; 13():997765. PubMed ID: 36275664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma.
    Xu F; Yan J; Peng Z; Liu J; Li Z
    Front Immunol; 2022; 13():1096009. PubMed ID: 36618348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tumor microenvironment-based prognostic index for osteosarcoma.
    Wu C; Gong S; Duan Y; Deng C; Kallendrusch S; Berninghausen L; Osterhoff G; Schopow N
    J Biomed Sci; 2023 Apr; 30(1):23. PubMed ID: 37055822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenic cell death related mRNAs associated signature to predict immunotherapeutic response in osteosarcoma.
    Han S; Wang Q; Shen M; Zhang X; Wang J
    Heliyon; 2024 Mar; 10(6):e27630. PubMed ID: 38515694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the immune microenvironment of osteosarcoma through T cell exhaustion-associated gene expression: a study on prognosis prediction.
    Zhu J; Yuan J; Arya S; Du Z; Liu X; Jia J
    Front Immunol; 2023; 14():1265098. PubMed ID: 38169731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma.
    Su Z; Wang C; Pan R; Li H; Chen J; Tan J; Tian X; Lin T; Shen J
    Front Immunol; 2022; 13():1028263. PubMed ID: 36275679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a 5-gene prognostic signature based on oxidative stress related genes for predicting prognosis in osteosarcoma.
    Hong X; Fu R
    PLoS One; 2023; 18(12):e0295364. PubMed ID: 38039294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma.
    Lei T; Qian H; Lei P; Hu Y
    Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bioinformatics analysis of differently expressed genes in osteoblastic sarcoma and screening of key genes].
    Shen RK; Huang Z; Zhu X; Lin JH
    Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):147-154. PubMed ID: 35184458
    [No Abstract]   [Full Text] [Related]  

  • 14. Anoikis patterns exhibit distinct prognostic and immune landscapes in Osteosarcoma.
    Zhang Z; Zhu Z; Fu J; Liu X; Mi Z; Tao H; Fan H
    Int Immunopharmacol; 2023 Feb; 115():109684. PubMed ID: 36630752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma.
    Liu Z; Liu B; Feng C; Li C; Wang H; Zhang H; Liu P; Li Z; He S; Tu C
    Front Immunol; 2022; 13():1071636. PubMed ID: 36569869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A risk score model based on endoplasmic reticulum stress related genes for predicting prognostic value of osteosarcoma.
    Zhao Y; Gao J; Fan Y; Xu H; Wang Y; Yao P
    BMC Musculoskelet Disord; 2023 Jun; 24(1):519. PubMed ID: 37353812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of neutrophil extracellular traps-derived signature to predict the prognosis for osteosarcoma patients.
    Lin Y; Tang H; Teng H; Feng W; Li F; Liu S; Liu Y; Wei Q
    Int Immunopharmacol; 2024 Jan; 127():111364. PubMed ID: 38101221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.
    Yang H; Zhao L; Zhang Y; Li FF
    Cancer Med; 2021 Aug; 10(16):5696-5711. PubMed ID: 34258887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a 3-gene signature based on differentially expressed invasion genes related to cancer molecular subtypes to predict the prognosis of osteosarcoma patients.
    Wan Y; Qu N; Yang Y; Ma J; Li Z; Zhang Z
    Bioengineered; 2021 Dec; 12(1):5916-5931. PubMed ID: 34488541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma.
    Liu B; Liu Z; Feng C; Li C; Zhang H; Li Z; Tu C; He S
    Front Endocrinol (Lausanne); 2022; 13():987942. PubMed ID: 36313774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.